These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6382483)

  • 21. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia. I. Predictive parameters in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer; 1984 Dec; 54(11):2456-9. PubMed ID: 6594187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promyelocytic crisis of chronic myelogenous leukemia without t(15;17).
    Abe R; Shichishima T; Kawaguchi M; Uchida T; Kariyone S
    Cancer Genet Cytogenet; 1986 Mar; 21(2):175-9. PubMed ID: 3456258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP; Butturini A
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract]   [Full Text] [Related]  

  • 25. [Leukapheresis of patients with acute leukemia and chronic myelogenous leukemia (author's transl)].
    Kawashima K; Ueda R
    Rinsho Ketsueki; 1977 May; 18(5):620-6. PubMed ID: 269295
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
    Amadori S; Picardi A; Fazi P; Testi AM; Petti MC; Montefusco E; Mandelli F
    Leukemia; 1996 May; 10(5):766-8. PubMed ID: 8656669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic myelogenous leukemia--new concepts (second of two parts).
    Koeffler HP; Golde DW
    N Engl J Med; 1981 May; 304(21):1269-74. PubMed ID: 7012625
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of chronic granulocytic leukemia in blastic crisis.
    Canellos GP
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemia.
    Testa NG; Coutinho L; Chang J; Morgenstern G; Scarffe JH; Dexter TM
    Haematol Blood Transfus; 1987; 31():75-8. PubMed ID: 3327789
    [No Abstract]   [Full Text] [Related]  

  • 30. [How extensive are the present indications for bone marrow transplantation?].
    Gmür J
    Schweiz Med Wochenschr; 1985 May; 115(21):738-43. PubMed ID: 3892662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of chronic myelogenous leukemia (CML), whose initial sign of blastic crisis appeared as myeloblastoma in the epiphysis of the right tibia (author's transl)].
    Imaoka T; Mizuno T; Okita H; Okada K; Kamada N
    Rinsho Ketsueki; 1976 Nov; 17(11):1174-83. PubMed ID: 1070532
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy of chronic myeloid leukemia (CML): interim report on protocols CML/73 and CML/74.
    Baccarani M; Ruggero D; Tura S
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):278-88. PubMed ID: 367386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine infiltration as first sign of acute myeloid leukemia.
    Matthes T; Collao C; Samii K; Chapuis B; Girardet C; Diebold-Berger S
    Am J Hematol; 1999 Mar; 60(3):253-4. PubMed ID: 10072130
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bone marrow transplantation after intensive chemotherapy].
    Masaoka T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in acute myelogenous leukemia.
    Gale RP
    Ann Intern Med; 1984 Nov; 101(5):702-5. PubMed ID: 6385800
    [No Abstract]   [Full Text] [Related]  

  • 36. Granulocytic sarcoma of the intestine as a primary manifestation nine months prior to overt acute myelogenous leukemia.
    Toki H; Okabe K; Kimura Y; Kiura K; Shibata H; Hara K; Moriwaki S; Nanbu T; Iwashita A
    Jpn J Clin Oncol; 1987 Mar; 17(1):79-85. PubMed ID: 3470535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.
    Koc Y; Miller KB; Schenkein DP; Daoust P; Sprague K; Berkman E
    Cancer; 1999 Feb; 85(3):608-15. PubMed ID: 10091734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive acral erythema occurring during therapy for severe myelogenous leukemia.
    Levine LE; Medenica MM; Lorincz AL; Soltani K; Raab B; Ma A
    Arch Dermatol; 1985 Jan; 121(1):102-4. PubMed ID: 3855356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological and histoenzymatic characteristics of the bone marrow in the blastic crisis of chronic myeloleukosis].
    Khittsov GA
    Vopr Onkol; 1978; 24(1):24-9. PubMed ID: 273347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-remission treatment of acute myelogenous leukemia.
    Löwenberg B
    N Engl J Med; 1995 Jan; 332(4):260-2. PubMed ID: 7808494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.